June 2, 2020 / 8:32 AM / a month ago

BRIEF-Qlife To Develop SARS-Cov-2 Total Antibody Test

June 2 (Reuters) - Qlife Holding AB:

* QLIFE TO DEVELOP SARS-COV-2 TOTAL ANTIBODY TEST

* EXPECTS TO BE ABLE TO CE MARK FOR PROFESSIONAL USE LATE 2020 AND SUBMIT A FILE FOR CE MARK HOME USE DURING Q1 2021.

* FIRST PHASE OF DEVELOPING ANTIBODY TEST WILL BE OUTSOURCED TO AN EXISTING PARTNER AND IS EXPECTED TO TAKE APPROXIMATELY THREE MONTHS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below